These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 27120388

  • 1. Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations - a randomized trial in Latvia.
    Santare D, Kojalo I, Liepniece-Karele I, Kikuste I, Tolmanis I, Polaka I, Vikmanis U, Boka V, Leja M.
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):904-10. PubMed ID: 27120388
    [Abstract] [Full Text] [Related]

  • 2. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
    de Klerk CM, Wieten E, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MC, Dekker E.
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
    [Abstract] [Full Text] [Related]

  • 3. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mundt MW, Spijker WJ, Bongers EJC, Kuipers EJ, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.
    Gut; 2017 Nov; 66(11):1975-1982. PubMed ID: 27507905
    [Abstract] [Full Text] [Related]

  • 4. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [Abstract] [Full Text] [Related]

  • 5. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
    Faivre J, Dancourt V, Manfredi S, Denis B, Durand G, Gendre I, Bidan JM, Jard C, Levillain R, Jung S, Viguier J, Dorval E.
    Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
    [Abstract] [Full Text] [Related]

  • 6. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer.
    Faivre J, Dancourt V, Denis B, Dorval E, Piette C, Perrin P, Bidan JM, Jard C, Jung S, Levillain R, Viguier J, Bretagne JF.
    Eur J Cancer; 2012 Nov; 48(16):2969-76. PubMed ID: 22572481
    [Abstract] [Full Text] [Related]

  • 7. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E, Carrillo M, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Díez-Fuentes ML, Abraira V.
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
    Hamza S, Dancourt V, Lejeune C, Bidan JM, Lepage C, Faivre J.
    Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
    [Abstract] [Full Text] [Related]

  • 9. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H, Tao S.
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [Abstract] [Full Text] [Related]

  • 10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [Abstract] [Full Text] [Related]

  • 11. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    Digby J, Fraser CG, Carey FA, Diament RH, Balsitis M, Steele RJ.
    J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
    [Abstract] [Full Text] [Related]

  • 12. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L, Swan N, Hughes DJ.
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [Abstract] [Full Text] [Related]

  • 13. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G.
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [Abstract] [Full Text] [Related]

  • 14. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program.
    Chiang TH, Chuang SL, Chen SL, Chiu HM, Yen AM, Chiu SY, Fann JC, Chou CK, Lee YC, Wu MS, Chen HH.
    Gastroenterology; 2014 Dec; 147(6):1317-26. PubMed ID: 25200099
    [Abstract] [Full Text] [Related]

  • 15. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
    Haug U, Hundt S, Brenner H.
    Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
    [Abstract] [Full Text] [Related]

  • 16. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A, Stieber P, Nagel D, Schäfer C, Horst D, Becker CR, Nikolaou K, Lottes A, Geisbüsch S, Kramer H, Wagner AC, Diepolder H, Schirra J, Roth HJ, Seidel D, Göke B, Reiser MF, Kolligs FT.
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [Abstract] [Full Text] [Related]

  • 17. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
    Raginel T, Puvinel J, Ferrand O, Bouvier V, Levillain R, Ruiz A, Lantieri O, Launoy G, Guittet L.
    Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
    [Abstract] [Full Text] [Related]

  • 18. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y.
    Aliment Pharmacol Ther; 2009 Apr 15; 29(8):906-17. PubMed ID: 19183147
    [Abstract] [Full Text] [Related]

  • 19. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
    Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, Launoy G.
    Int J Cancer; 2009 Sep 01; 125(5):1127-33. PubMed ID: 19431212
    [Abstract] [Full Text] [Related]

  • 20. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    Santare D, Kojalo I, Huttunen T, Rikacovs S, Rucevskis P, Boka V, Leja M.
    Eur J Gastroenterol Hepatol; 2015 May 01; 27(5):536-43. PubMed ID: 25806603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.